AMSG
Income statement / Annual
Last year (2015), AmSurg Corp's total revenue was $2.57 B,
an increase of 58.26% from the previous year.
In 2015, AmSurg Corp's net income was $162.95 M.
See AmSurg Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
FY-2007
|
FY-2006
|
| Period Ended |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
12/31/2010 |
12/31/2009 |
12/31/2008 |
12/31/2007 |
12/31/2006 |
| Operating Revenue |
$2.57 B |
$1.62 B |
$1.08 B |
$928.51 M |
$786.87 M |
$710.41 M |
$668.75 M |
$600.66 M |
$531.09 M |
$464.59 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$2.57 B
|
$1.62 B
|
$1.08 B
|
$928.51 M
|
$786.87 M
|
$710.41 M
|
$668.75 M
|
$600.66 M
|
$531.09 M
|
$464.59 M
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.31 B
|
$694.58 M
|
$333.19 M
|
$291.71 M
|
$243.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.31 B
|
$694.58 M
|
$333.19 M
|
$291.71 M
|
$243.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$687.83 M
|
$543.46 M
|
$413.48 M
|
$356.42 M
|
$301.94 M
|
$481.13 M
|
$443.39 M
|
$390.19 M
|
$345.02 M
|
$301.45 M
|
| Operating Expenses |
$2.00 B
|
$1.24 B
|
$746.67 M
|
$648.13 M
|
$545.04 M
|
$481.13 M
|
$443.39 M
|
$390.19 M
|
$345.02 M
|
$301.45 M
|
| Cost And Expenses |
$2.00 B
|
$1.24 B
|
$746.67 M
|
$648.13 M
|
$545.04 M
|
$481.13 M
|
$443.39 M
|
$390.19 M
|
$345.02 M
|
$301.45 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$121.59 M
|
$83.29 M
|
$29.54 M
|
$16.97 M
|
$15.35 M
|
$0.00
|
-$7.79 M
|
-$9.94 M
|
-$9.78 M
|
-$7.69 M
|
| Depreciation & Amortization |
$105.86 M
|
$78.06 M
|
$33.03 M
|
$30.08 M
|
$26.18 M
|
$24.91 M
|
$22.93 M
|
$20.88 M
|
$19.49 M
|
$17.37 M
|
| EBITDA |
$504.18 M |
$263.15 M |
$185.02 M |
$152.24 M |
$127.36 M |
$240.82 M |
$232.71 M |
$92.91 M |
$81.00 M |
$71.98 M |
| EBITDA Ratio |
0.2
|
0.16
|
0.17
|
0.16
|
0.16
|
0.34
|
0.35
|
0.15
|
0.15
|
0.15
|
| Operating Income Ratio |
0.24
|
0.24
|
0.31
|
0.3
|
0.31
|
0.32
|
0.34
|
0.35
|
0.35
|
0.35
|
| Total Other Income/Expenses Net |
-$121.59 M
|
-$100.17 M
|
-$29.54 M
|
-$16.97 M
|
-$15.35 M
|
-$13.37 M
|
-$7.79 M
|
-$128.49 M
|
-$114.78 M
|
-$100.84 M
|
| Income Before Tax |
$495.92 M
|
$294.19 M
|
$308.53 M
|
$264.97 M
|
$227.10 M
|
$215.91 M
|
$217.58 M
|
$81.98 M
|
$71.29 M
|
$62.30 M
|
| Income Before Tax Ratio |
0.19
|
0.18
|
0.29
|
0.29
|
0.29
|
0.3
|
0.33
|
0.14
|
0.13
|
0.13
|
| Income Tax Expense |
$113.79 M
|
$48.10 M
|
$49.75 M
|
$42.63 M
|
$35.84 M
|
$34.32 M
|
$35.69 M
|
$32.46 M
|
$27.73 M
|
$24.19 M
|
| Net Income |
$162.95 M
|
$53.70 M
|
$72.70 M
|
$62.56 M
|
$50.00 M
|
$181.59 M
|
$181.89 M
|
$49.51 M
|
$43.55 M
|
$38.11 M
|
| Net Income Ratio |
0.06
|
0.03
|
0.07
|
0.07
|
0.06
|
0.26
|
0.27
|
0.08
|
0.08
|
0.08
|
| EPS |
3.39 |
1.37 |
2.32 |
2.03 |
1.64 |
5.96 |
5.95 |
1.57 |
1.42 |
1.28 |
| EPS Diluted |
3.16 |
1.36 |
2.28 |
1.98 |
1.6 |
5.96 |
5.89 |
1.55 |
1.4 |
1.25 |
| Weighted Average Shares Out |
$48.06 M
|
$39.31 M
|
$31.34 M
|
$30.77 M
|
$30.45 M
|
$30.45 M
|
$30.58 M
|
$31.50 M
|
$30.62 M
|
$29.82 M
|
| Weighted Average Shares Out Diluted |
$51.61 M
|
$39.63 M
|
$31.95 M
|
$31.61 M
|
$31.21 M
|
$30.45 M
|
$30.86 M
|
$31.96 M
|
$31.10 M
|
$30.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
